tcypherbio Revenue and Competitors
Estimated Revenue & Valuation
- tcypherbio's estimated annual revenue is currently $5M per year.
- tcypherbio's estimated revenue per employee is $155,000
Employee Data
- tcypherbio has 32 Employees.
- tcypherbio grew their employee count by 10% last year.
tcypherbio's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Computational Biology | Reveal Email/Phone |
3 | Senior Bioinformatician | Reveal Email/Phone |
4 | Senior Bioinformatician | Reveal Email/Phone |
5 | Senior Scientist - Cell Biology | Reveal Email/Phone |
tcypherbio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is tcypherbio?
T-Cypher Bio is an early-stage, innovative biotechnology company based in Oxford, UK. We believe that TCR-based therapeutics have the potential to transform the treatment of solid tumours, as well as autoimmune, inflammatory, and infectious diseases. Yet challenges in the identification of therapeutically relevant targets and TCRs has limited the application of such therapies. T-Cypher's integrated platform, D-Cypher, overcomes these challenges.
keywords:N/AN/A
Total Funding
32
Number of Employees
$5M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.6M | 32 | 7% | N/A |
#2 | $8.4M | 32 | 14% | N/A |
#3 | $4.5M | 32 | -3% | N/A |
#4 | N/A | 32 | 39% | N/A |
#5 | $8M | 32 | -52% | N/A |